The U.S. Food and Drug Administration today allowed marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient’s intraocular pressure (IOP). Elevated IOP is often associated with the optic nerve damage that is characteristic of glaucoma.
from Food and Drug Administration--Press Releases http://ift.tt/1oWxlfC
via IFTTT
No comments:
Post a Comment